throbber
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`AMERIGEN PHARMACEUTICALS LIMITED
`
`and
`
`ARGENTUM PHARMACEUTICALS LLC,
`
`Petitioners
`
`v.
`
`JANSSEN ONCOLOGY, INC.,
`
`Patent Owner
`_______________
`
`Case IPR2016-002861
`
`Patent 8,822,438 B2
`_______________
`
`
`
`PETITIONERS’ OPPOSITION TO PATENT OWNER’S
`
`MOTION TO EXCLUDE EVIDENCE
`
`
`
`
`
`
`
`1 Case IPR2016-01317 has been joined with this proceeding.
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`Petitioners, Amerigen Pharmaceuticals Limited and Argentum
`
`Pharmaceuticals LLC, oppose Patent Owner’s, Janssen Oncology, Inc., Motion to
`
`Exclude Evidence submitted by Petitioners.
`
`I. Declarations and related Exhibits of Deforest McDuff (economic
`
`expert).
`
`
`
`Patent Owner argues that all the evidence submitted by Petitioners
`
`concerning commercial success should be excluded. As Patent Owner correctly
`
`points out, commercial success can be relevant to the issue of obviousness of a
`
`patent claim. In this instance, the Patent Owner itself attempted to claim
`
`commercial success as an objective indicia of non-obviousness in Patent Owner’s
`
`Response. (See Patent Owner’s Response at p. 60).
`
`There is no basis in law or common sense suggesting that Patent Owner can
`
`attempt to establish non-obviousness with evidence of commercial success in the
`
`course of prosecuting a patent, and then again during an IPR proceeding, but that
`
`Petitioners are prohibited from addressing such, commenting upon, and offering its
`
`own evidence on the issue. Tellingly, Patent Owner cites to no regulation or case
`
`law on the issue.
`
`Patent Owner’s issue with Dr. McDuff’s first declaration (Exh. 1017) seems
`
`to be that it was offered prior in time to Patent Owner’s Response and is therefore
`
`not technically a “rebuttal.” Dr. McDuff’s first declaration was necessitated by the
`
`2
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`original prosecution record leading to the issuance of the ‘438 Patent in the first
`
`instance. Patent Owner overlooks that critically, in the case of the ‘438 Patent,
`
`patentees were only able to overcome compelling prior art rejections based on
`
`“commercial showings.” Dr. McDuff’s Declaration necessarily addresses the
`
`original prosecution record. Patent Owner cannot expect Petitioners and the Board
`
`to not consider the grounds on which the ‘438 patent issued in the first instance.
`
`Again, Patent Owner offers no case law to support this notion that such evidence
`
`must be offered in the Reply as opposed to the Petition itself.
`
`Finally, Patent Owner claims that Dr. McDuff’s second declaration
`
`(currently labeled Exh. 1152) is not cited in Petitioners’ Reply. As is known to the
`
`Patent Owner, Dr. McDuff’s second declaration was inadvertently labeled as
`
`Exhibit 1152. However, the second McDuff Declaration is cited as Exhibit 1096 in
`
`Petitioners’ Reply brief and Exhibits 1149, 1150, 1151 and 1190 are cited in the
`
`second McDuff declaration. Petitioners have approached the Board to correct the
`
`clerical error. There has been no prejudice to Patent Owner in this regard, as
`
`counsel fully considered Dr. McDuff’s second declaration and exhibits, and indeed
`
`deposed him on it. Exh. 1191. During the deposition of Dr. McDuff the Patent
`
`Owner did not make any objections that the testimony was irrelevant. It is illogical
`
`3
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`that Patent Owner has objected to Dr. McDuff’s Declaration but did not object to
`
`Dr. McDuff’s deposition based upon his declaration.
`
`II. Certain of Petitioners’ Exhibits to Its Reply Brief Filed and
`
`Served After Midnight.
`
`
`
`Patent Owner admits that Petitioners’ Reply brief and four expert
`
`declarations accompanying its Reply brief were timely filed but complains that the
`
`exhibits were filed after midnight. Patent Owner relies solely on Teva
`
`Pharmaceuticals USA, Inc. v. Monosol RX, LLC, IPR2016- 00281, -00282, Papers
`
`21 and 19 (PTAB May 23, 2016) for the notion that the exhibits should be stricken.
`
`Patent Owner fails to mention that Teva however missed a statutory bar for the
`
`filing of a Petition. There is no such bar here, and in the interest of justice the
`
`exhibits should not be stricken.
`
`The Patent Owner does not make an actual claim of prejudice and there was
`
`none. First, Petitioners note that January 16, 2017 was a national holiday, the
`
`USPTO was officially closed, and Patent Owner received all exhibits prior to open
`
`of business on the morning of the first business day following the holiday. Second,
`
`the Patent Owner took all of the depositions of Petitioners’ experts as scheduled.
`
`Patent Owner did not request additional time to prepare or otherwise object until
`
`after it took each of the depositions. Further, Patent Owner elected not to use more
`
`than half of its allotted time for each deposition.
`
`4
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`Finally, Patent Owner’s subtle suggestion of gamesmanship is unwarranted.
`
`Petitioners experienced technical problems during the filing which caused the
`
`delay. Petitioners have always cooperated with Patent Owner including giving
`
`Patent Owner two extensions totaling approximately five weeks (August 31 to
`
`October 4) to file its Preliminary Response and working with Patent Owner to
`
`schedule depositions of the four experts relied upon in Petitioners’ Reply in
`
`advance of filing the Reply. With regard to the five hour delay in filing the
`
`exhibits to the Petitioners’ Reply, Petitioners, in response to Patent Owner’s
`
`Objection served on January 23, 2017, have requested that the Patent Owner
`
`stipulate to an extension of the deadline from January 16 to January 17 but Patent
`
`Owner rejected such a stipulation.
`
`III. Paragraphs of Petitioners’ Reply Declarations Not Explicitly
`
`Recited in Petitioners’ Reply.
`
`
`
`Patent Owner, citing no statute, regulation, or case law, complains that any
`
`paragraph of an expert declaration not explicitly cited in Petitioners’ Reply brief
`
`should be stricken. There is simply no legal basis for striking these paragraphs.
`
`Patent Owner’s sole basis for arguing irrelevance is the lack of citation in the
`
`Reply brief. Patent Owner did not examine the substance of any paragraphs it
`
`moved to exclude. That is, Patent Owner failed to consider that the paragraphs at
`
`5
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`issue are relevant to the portions of the expert declarations that are cited in the
`
`Reply brief.
`
`It is extremely common for expert declarations to contain information that is
`
`not directly cited in a party’s brief. Expert declarations almost always contain
`
`information relevant to the expert’s opinions that are not cited by paragraph
`
`number in the brief. In fact, Patent Owner’s own expert declarations are replete
`
`with paragraphs that are not cited in Patent Owner’s own Response brief.
`
`With regard to Dr. McDuff’s second declaration, as explained above, this
`
`was inadvertently labeled as Exhibit 1152. However, the second McDuff
`
`Declaration is cited as Exhibit 1096 in Petitioners’ Reply brief. Patent Owner has
`
`denied Petitioners’ request to correct this clerical error. Patent Owner has denied
`
`this request in spite of Petitioners previous consent for Patent Owner to correct not
`
`just clerical errors, but changes more substantive in nature to its own expert’s
`
`declaration. Accordingly Petitioner has approached the Board to correct the
`
`clerical error.
`
`
`
`IV. Petitioners Exhibits Objected to Due to Lack of Authenticity and
`
`Hearsay.
`A. Authenticity
`
`
`Patent Owner initially objected to Exhibits 1040, 1041, 1048, 1049, 1051-
`
`1053, 1055-1057, 1088, 1128, 1130, 1140, and 1166 as lacking authenticity.
`
`6
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`Petitioner timely responded to each objection and timely served supplemental
`
`evidence authenticating each of these exhibits2. In particular, Petitioners provided
`
`the declarations of DeForest McDuff and Scott Serels as Exhibits 1068 and 1069,
`
`respectively, that authenticated the objected-to exhibits. Yet, in its motion, Patent
`
`Owner fails to identify any alleged deficiency in the authentication contained in the
`
`supplemental evidence (or address the supplemental evidence at all).
`
`Patent Owner similarly complains that Exhibits 1017 [B-1 and B-2], 1032,
`
`1042-1044, 1058-1063, 1067, and 1140 lack authentication. Again, Petitioners
`
`timely responded to each objection and timely served supplemental evidence
`
`authenticating each of these exhibits.3 In particular, Petitioners provided the
`
`declarations of DeForest McDuff, Scott Serels, and Jayesh Bindra as Exhibits
`
`1068, 1069 and 1070, respectively, authenticating the exhibits. In its motion,
`
`Patent Owner again failed to identify any the alleged deficiency in the
`
`authentication contained in the supplemental evidence (or address the supplemental
`
`evidence at all).
`
`
`
`2 Due to the schedule Petitioners will timely file supplemental evidence
`authenticating Exhibits 1088, 1128, 1130, 1140, and 1166.
`
` 3
`
` Due to the schedule Petitioners will timely file supplemental evidence
`authenticating Exhibit 1140.
`
`7
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`For example, Patent Owner complains that Exhibit 1032, “purports to be the
`
`‘Taxotere® Prescribing Information’, but this exhibit lacks proper authentication
`
`and foundation at least because the circumstances surrounding the source and the
`
`accuracy of the ‘Taxotere® Prescribing Information’ have not been established.”
`
`Yet the declaration of Scott Serels describes in detail where the document is found
`
`on the Food and Drug Administration website and swears it is a true and correct
`
`copy of such document. See Exh. 1069 at 7.
`
`Patent Owner makes similar complaints about the other documents while
`
`seemingly ignoring the Petitioners’ supplemental evidence, i.e., Exhibits 1068,
`
`1069 and 1070. Instead Patent Owner makes general conclusory statements about
`
`Petitioners’ exhibits while failing to address the actual statements in Petitioners’
`
`declarations. Tellingly, the supplemental evidence provided by Patent Owner to
`
`authenticate exhibits provides less information than Petitioners have provided in
`
`their supplemental evidence.
`
`B. Hearsay
`
`Patent Owners assert that Exhibits 1042-1044, 1055, 1056, 1058-1063, and
`
`1067 are hearsay. All the objected to exhibits fall into an exception under Federal
`
`Rules of Evidence 803.
`
`8
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`Patent Owner objects to Exhibits 1042-1044, 1056, and 1058-1063 and
`
`correctly characterize these as investment analyst reports. These documents
`
`clearly fall within the exception to the hearsay Rule 803(17), which states:
`
`“Market Reports and Similar Commercial Publications. Market quotations, lists,
`
`directories, or other compilations that are generally relied on by the public or by
`
`persons in particular occupations.” Dr. McDuff relied on these commercial
`
`publications as a person in the occupation of consulting in applied business
`
`economics. Dr. McDuff explicitly identifies these documents as research material
`
`in his Declaration (Exh. 1017, attachment A2). Patent Owner fails to prove or
`
`even argue that the documents are not generally relied on by the public or by
`
`persons in Dr. McDuff’s occupational field.
`
`Additionally, Exhibits 1055 and 1067 are similarly reports of the type
`
`generally relied on by persons in Dr. McDuff’s occupation. For example, Patent
`
`Owner’s own economics expert, Dr. Christopher Vellturo, relied on both
`
`documents in the formation of his opinion. See Exh. 2044, Appendix A. Further,
`
`while Dr. Vellturo’s declaration purports to evaluate Dr. McDuff’s analysis, Dr.
`
`Vellturo failed to assert that any of the objected to exhibits were not generally
`
`relied on by the public or by persons in particular occupations.
`
`None of the exhibits should be excluded as hearsay.
`
`9
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`
`
`
`
`Dated: February 3, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`/William D. Hare/
`William D. Hare
`Reg. No. 44,739
`McNeely Hare & War, LLP
`12 Roszel Road, Suite C104
`Princeton, NJ 08540
`(202) 640-1801
`bill@miplaw.com
`
`10
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing Petitioners’ Opposition
`
`to Patent Owner’s Motion to Exclude Evidence was served on February 3, 2017 by
`
`delivering copies via electronic mail on the following attorneys of record for the
`
`Patent Owner:
`
`Dianne B. Elderkin
`Barbara L. Mullin
`Ruben H. Munoz
`delderkin@akingump.com
`bmullin@akingump.com
`rmunoz@akingump.com
`JANS-ZYTIGA@akingump.com
`AKIN GUMP STRAUSS HAUER & FELD LLP
`
`David T. Pritikin
`Bindu Donovan
`Paul J. Zegger
`Todd Krause
`Isaac Olson
`Alyssa B. Monsen
`dpritikin@sidley.com
`bdonovan@sidley.com
`pzegger@sidley.com
`tkrause@sidley.com
`iolson@sidley.com
`amonsen@sidley.com
`ZytigaIPRTeam@sidley.com
`SIDLEY AUSTIN LLP
`
`Jennifer H. Roscetti
`Anthony C. Tridico
`jennifer.roscetti@finnegan.com
`anthony.tridico@finnegan.com
`FINNEGAN HENDERSON FARABOW GARRETT & DUNNER
`
`11
`
`

`

`Petitioners’ Opposition To Patent Owner’s Motion To Exclude Evidence
`Petition for Inter Partes Review 2016-00286
`
`
`
`
`
`
`
`Teresa Stanek Rea
`Shannon M. Lentz
`TRea@Crowell.com
`SLentz@Crowell.com
`CROWELL & MORING LLP
`
`
`Date: February 3, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/William D. Hare/
`William D. Hare
`
`12
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket